Search

Displaying all 3 results
  1. Drug

    Ozanimod

    go.drugbank.com/drugs/DB12612
    ApprovedInvestigational

    Ozanimod is a once-daily sphingosine 1-phosphate receptor modulator for the treatment of relapsing Multiple Sclerosis (MS) and inflammatory bowel disease. … [L41524] In November 2021, ozanimod was also approved by the European Commission for the treatment of adults with relapsing remitting multiple sclerosis.

    Salts: Ozanimod hydrochlorideCategories: ozanimod
  2. Indication

    Relapsing Multiple Sclerosis (RMS)

    go.drugbank.com/conditions/DBCOND0044896
    Drugs: Cladribine · Daclizumab · Fingolimod · Interferon beta-1a · Interferon beta-1b · Ocrelizumab +5 more
  3. Indication

    Relapsing Remitting Multiple Sclerosis (RRMS)

    go.drugbank.com/conditions/DBCOND0036413
    Drugs: Alemtuzumab · Dimethyl fumarate · Diroximel fumarate · Glatiramer · Human interferon beta · Mitoxantrone +6 more